Yoshimasa Urasaki Selected Research

Yoshimasa Urasaki Research Topics

Disease

10	Leukemia 10/2014 - 08/2002
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2014 - 02/2007
3	Hematologic Neoplasms (Hematological Malignancy) 05/2015 - 01/2007
3	Neoplasms (Cancer) 10/2014 - 08/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2012 - 07/2007
2	Tumor Lysis Syndrome 05/2015 - 10/2014
2	Hematologic Diseases (Blood Diseases) 04/2013 - 03/2004
2	Disease Progression 04/2013 - 09/2012
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2010 - 09/2003
2	Philadelphia Chromosome 01/2007 - 09/2003
1	Infections 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2015
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2015
1	Lymphoma (Lymphomas) 06/2015
1	Bacteremia 04/2013
1	Neutropenia 04/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2012
1	Pancytopenia 10/2012
1	Refractory Anemia 09/2012
1	Genomic Instability 09/2012
1	Pathologic Complete Response 07/2007
1	Febrile Neutropenia 03/2004
1	Communicable Diseases (Infectious Diseases) 03/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2003
1	Starvation 03/2003
1	Poisoning 08/2002
1	Lung Neoplasms (Lung Cancer) 08/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2002

Drug/Important Bio-Agent (IBA)

6	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2012 - 03/2005
3	Uric Acid (Urate)IBA 05/2015 - 09/2013
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2012 - 03/2005
2	Mitoxantrone (Novantrone)FDA LinkGeneric 09/2015 - 07/2007
2	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015 - 03/2010
2	Messenger RNA (mRNA)IBA 08/2013 - 10/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2012 - 01/2007
2	Imatinib Mesylate (Gleevec)FDA Link 01/2007 - 09/2003
2	Arsenic Trioxide (Trisenox)FDA Link 01/2007 - 03/2005
2	CamptothecinIBA 03/2003 - 08/2002
1	VaccinesIBA 01/2023
1	Cladribine FDA LinkGeneric 09/2015
1	Rituximab (Mabthera)FDA Link 09/2015
1	rasburicase (Elitek)FDA Link 05/2015
1	Xanthine OxidaseIBA 10/2014
1	Febuxostat FDA Link 10/2014
1	Nucleic AcidsIBA 09/2013
1	A-Form DNA (A-DNA)IBA 04/2013
1	Ribosomal DNA (rDNA)IBA 04/2013
1	DNA (Deoxyribonucleic Acid)IBA 04/2013
1	Antineoplastic Agents (Antineoplastics)IBA 04/2013
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 11/2012
1	R-CHOP protocolIBA 11/2012
1	SurvivinIBA 09/2012
1	Aurora Kinase BIBA 09/2012
1	Aluminum Oxide (Sapphire)IBA 08/2011
1	Glutathione (Reduced Glutathione)IBA 03/2010
1	GlucocorticoidsIBA 03/2010
1	glutathione S-transferase M1IBA 03/2010
1	5'-Nucleotidase (5' Nucleotidase)IBA 06/2009
1	Arabinofuranosylcytosine TriphosphateIBA 06/2009
1	Deoxycytidine KinaseIBA 06/2009
1	Melphalan (Alkeran)FDA LinkGeneric 07/2007
1	fludarabineIBA 02/2007
1	2-fluoro-araATPIBA 02/2007
1	Tyrosine Kinase InhibitorsIBA 01/2007
1	bafetinibIBA 01/2007
1	multidrug resistance-associated protein 1IBA 03/2005
1	Multidrug Resistance-Associated ProteinsIBA 03/2005
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2004
1	Zoledronic Acid (Zometa)FDA Link 09/2003
1	Diphosphonates (Bisphosphonates)IBA 09/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2003
1	Proteins (Proteins, Gene)FDA Link 09/2003
1	Annexin A5IBA 03/2003
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2003
1	Cisplatin (Platino)FDA LinkGeneric 03/2003
1	Complementary DNA (cDNA)IBA 03/2003
1	StaurosporineIBA 03/2003
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2002
1	OligodeoxyribonucleotidesIBA 08/2002
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2002
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2002
1	Gemcitabine FDA Link 08/2002

Therapy/Procedure

8	Therapeutics 09/2015 - 08/2002
4	Drug Therapy (Chemotherapy) 06/2015 - 01/2007